Results
|
41.
|
Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis. [electronic resource] by
- van Stolk, R
- Stoner, G
- Hayton, W L
- Chan, K
- DeYoung, B
- Kresty, L
- Kemmenoe, B H
- Elson, P
- Rybicki, L
- Church, J
- Provencher, K
- McLain, D
- Hawk, E
- Fryer, B
- Kelloff, G
- Ganapathi, R
- Budd, G T
Producer: 20000228
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 6
Availability: No items available.
|
|
42.
|
A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. [electronic resource] by
- Phillips, R K S
- Wallace, M H
- Lynch, P M
- Hawk, E
- Gordon, G B
- Saunders, B P
- Wakabayashi, N
- Shen, Y
- Zimmerman, S
- Godio, L
- Rodrigues-Bigas, M
- Su, L-K
- Sherman, J
- Kelloff, G
- Levin, B
- Steinbach, G
Producer: 20020710
In:
Gut vol. 50
Availability: No items available.
|
|
43.
|
Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2. [electronic resource] by
- Chang, K
- Willis, J A
- Reumers, J
- Taggart, M W
- San Lucas, F A
- Thirumurthi, S
- Kanth, P
- Delker, D A
- Hagedorn, C H
- Lynch, P M
- Ellis, L M
- Hawk, E T
- Scheet, P A
- Kopetz, S
- Arts, J
- Guinney, J
- Dienstmann, R
- Vilar, E
Producer: 20191125
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 29
Availability: No items available.
|
|
44.
|
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. [electronic resource] by
- Steinbach, G
- Lynch, P M
- Phillips, R K
- Wallace, M H
- Hawk, E
- Gordon, G B
- Wakabayashi, N
- Saunders, B
- Shen, Y
- Fujimura, T
- Su, L K
- Levin, B
- Godio, L
- Patterson, S
- Rodriguez-Bigas, M A
- Jester, S L
- King, K L
- Schumacher, M
- Abbruzzese, J
- DuBois, R N
- Hittelman, W N
- Zimmerman, S
- Sherman, J W
- Kelloff, G
Producer: 20000629
In:
The New England journal of medicine vol. 342
Availability: No items available.
|
|
45.
|
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. [electronic resource] by
- Bhala, N
- Emberson, J
- Merhi, A
- Abramson, S
- Arber, N
- Baron, J A
- Bombardier, C
- Cannon, C
- Farkouh, M E
- FitzGerald, G A
- Goss, P
- Halls, H
- Hawk, E
- Hawkey, C
- Hennekens, C
- Hochberg, M
- Holland, L E
- Kearney, P M
- Laine, L
- Lanas, A
- Lance, P
- Laupacis, A
- Oates, J
- Patrono, C
- Schnitzer, T J
- Solomon, S
- Tugwell, P
- Wilson, K
- Wittes, J
- Baigent, C
Producer: 20130916
In:
Lancet (London, England) vol. 382
Availability: No items available.
|
|
46.
|
Strategy and planning for chemopreventive drug development: clinical development plans II. [electronic resource] by
- Kelloff, G J
- Crowell, J A
- Hawk, E T
- Steele, V E
- Lubet, R A
- Boone, C W
- Covey, J M
- Doody, L A
- Omenn, G S
- Greenwald, P
- Hong, W K
- Parkinson, D R
- Bagheri, D
- Baxter, G T
- Blunden, M
- Doeltz, M K
- Eisenhauer, K M
- Johnson, K
- Knapp, G G
- Longfellow, D G
- Malone, W F
- Nayfield, S G
- Seifried, H E
- Swall, L M
- Sigman, C C
Producer: 19970717
In:
Journal of cellular biochemistry. Supplement vol. 26
Availability: No items available.
|